Open Accessibility Menu

COVID Treatments

Monoclonal Antibody Treatment

Monoclonal antibody treatment is an emergency use authorized treatment for eligible patients with mild or moderate COVID-19 symptoms, and in some cases to prevent COVID-19 after being exposed. When administered within 10 days of their first symptoms appearing, it can significantly reduce your risk of hospitalization, minimize the severity of symptoms and help you recover more quickly. This treatment is approved for all ages. Learn more.

Antiviral Treatments

The U.S. Food and Drug Administration recently approved two antiviral drugs with emergency use authorization for the treatment of COVID-19. Doctors may prescribe this treatment to Individuals with mild or moderate COVID, but with the potential to become seriously ill, such as those 65 and older and those with chronic illness.